First U.S. resolution to shine spotlight on crisis affecting 246 million
PRINCETON, N.J., Nov. 21 /PRNewswire-FirstCall/ -- On the eve of World Diabetes Day, leaders in the U.S. House of Representatives passed House Concurrent Resolution 211 supporting the goals and ideals of World Diabetes Day, which is recognized annually on November 14. Then, the next day, on World Diabetes Day itself, the U.S. Senate followed suit, passing Senate Resolution 382. More than 20 million Americans have diabetes, and that number is expected to double by 2025.
Passage of the U.S. resolution marks the first time Congress has officially supported World Diabetes Day since it was established in 1991 by the World Health Organization and the International Diabetes Federation, of which Novo Nordisk is a member. It represents an important milestone in a busy month of activities taking place as part of National Diabetes Month.
As the lead industry supporter of the resolution, Novo Nordisk and its National Changing Diabetes(R) Program have worked closely with many of the resolution sponsors, including Reps. Donald Payne (D-N.J.) and Donald Manzullo (R-Ill.) and Sens. Debbie Stabenow (D-Mich.), Pete Domenici (R-N.M.), Frank Lautenberg (D-N.J.) and Norman Coleman (R-Minn.) to help focus attention on diabetes and make the disease a top national health care priority.
"With over 80 years in diabetes care, Novo Nordisk commends the leadership and commitment of Representatives Payne and Manzullo and Senators Stabenow, Domenici, Lautenberg and Coleman, and the entire Congress. The attention and urgency these resolutions will bring to diabetes prevention and treatment efforts in the United States is a positive step forward in our shared passion of changing diabetes," said Martin Soeters, president of Novo Nordisk Inc.
The United Nations General Assembly passed a World Diabetes Day
Resolution on December 20, 2006, rec
|SOURCE Novo Nordisk|
Copyright©2007 PR Newswire.
All rights reserved